The provision of essential medications in Germany has become a matter of national security, according to health experts. The chair of the Pro Generika association has emphasized the critical need for Germany to integrate drug supply stability into its defense strategy, asserting that health is now a geostrategic asset. The current dependence on China for generic medications has raised alarms about the vulnerability of the German healthcare system, making it susceptible to political manipulation. This issue has escalated from a mere health policy concern to a pressing security matter amid shifting global power dynamics and ongoing trade conflicts. The expert argues that the new German government must address this urgent issue with a comprehensive strategy aimed at enhancing resilience in the healthcare supply chain. This strategy should focus on achieving greater diversification and independence within Europe. This perspective is echoed in an open letter from eleven EU health ministers, including Germany's own health minister, who have identified the nation's dependency on foreign drug supplies as a significant weakness in European defense policy. They assert that Europe can no longer treat medication security as a secondary issue, warning that such negligence could transform this reliance into a critical vulnerability for the continent's safety. The letter highlights the alarming fact that approximately 80 to 90 percent of the world's antibiotics are produced in Asia, primarily in China. The ministers caution that any disruption in the supply chain for these vital medications, especially in the event of an escalating conflict, could lead to catastrophic consequences for healthcare systems. Without access to antibiotics, routine surgeries could become perilous, and minor infections could turn fatal, posing a serious threat to public health. The letter from the health ministers serves as a rallying cry for urgent action, advocating for a reevaluation of how Europe approaches pharmaceutical independence and security. They emphasize that the consequences of inaction could severely compromise Europe's security and defense capabilities, making it imperative to reassess the current reliance on outside sources for essential medicines. In conclusion, the intersection of healthcare and national security is becoming increasingly prominent in policy discussions. As geopolitical tensions rise, ensuring the stability and independence of drug supplies is paramount for safeguarding public health and maintaining national security. The call for a strategic overhaul in how medications are sourced and supplied reflects a broader recognition of health as a critical element of security policy in an interconnected world.